共 50 条
- [22] The endocannabinoid system in the intestinal biopsies of children with Inflammatory Bowel Disease JOURNAL OF CROHNS & COLITIS, 2021, 15 : S178 - S179
- [25] The immune response in inflammatory bowel disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (09): : 2058 - 2069
- [26] Infliximab and immunomodulator combination therapy in inflammatory bowel disease - no longer inseparable? JOURNAL OF CROHNS & COLITIS, 2023, 17 : 930 - 931
- [27] Discontinuation of biologic therapy in Inflammatory Bowel Disease: longer term outcomes JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1250 - I1250
- [28] Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease JOURNAL OF CROHNS & COLITIS, 2023, : 489 - 496
- [29] Longer Duration of Response With Proactive Therapeutic Drug Monitoring for Infliximab but Not for Vedolizumab Treatment in Patients With Inflammatory Bowel Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S359 - S359